MetaStat Inc (MTST)
0.0005
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
MetaStat Research and Development Expense (TTM): 1.451M for Aug. 31, 2016
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| August 31, 2016 | 1.451M |
| May 31, 2016 | 1.412M |
| February 29, 2016 | 1.361M |
| November 30, 2015 | 1.178M |
| August 31, 2015 | 1.060M |
| May 31, 2015 | 1.221M |
| February 28, 2015 | 1.261M |
| November 30, 2014 | 1.428M |
| August 31, 2014 | 1.230M |
| May 31, 2014 | 0.7959M |
| Date | Value |
|---|---|
| February 28, 2014 | 0.6368M |
| November 30, 2013 | 0.3733M |
| August 31, 2013 | 0.328M |
| May 31, 2013 | 0.5605M |
| February 28, 2013 | 0.5168M |
| November 30, 2012 | 0.3505M |
| August 31, 2012 | 0.3965M |
| May 31, 2012 | 0.174M |
| February 29, 2012 | 0.4768M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Athersys Inc | 29.98M |
| Ampio Pharmaceuticals Inc | 2.439M |
| FluoroPharma Medical Inc | 0.5551M |
| Evolutionary Genomics Inc | 0.4175M |
| Xeno Transplants Corp | -- |